Evofem Biosciences, Inc. (EVFM)
EVFM Stock Price Chart
Explore Evofem Biosciences, Inc. interactive price chart. Choose custom timeframes to analyze EVFM price movements and trends.
EVFM Company Profile
Discover essential business fundamentals and corporate details for Evofem Biosciences, Inc. (EVFM) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
20 Nov 2014
Employees
32.00
Website
https://www.evofem.comCEO
Saundra Pelletier
Description
Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100, an antimicrobial vaginal gel for the prevention of urogenital transmission of Chlamydia trachomatis infection and Neisseria gonorrhoeae infection in women. Evofem Biosciences, Inc. is headquartered in San Diego, California.
EVFM Financial Timeline
Browse a chronological timeline of Evofem Biosciences, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 13 May 2026
Upcoming earnings on 23 Mar 2026
Upcoming earnings on 12 Nov 2025
Earnings released on 14 Aug 2025
EPS came in at -$0.02 , while revenue for the quarter reached $4.83M .
Earnings released on 15 May 2025
EPS came in at $0.00 , while revenue for the quarter reached $845.00K .
Earnings released on 24 Mar 2025
EPS came in at -$0.03 , while revenue for the quarter reached $7.10M .
Earnings released on 14 Nov 2024
EPS came in at -$0.02 , while revenue for the quarter reached $4.50M .
Earnings released on 14 Aug 2024
EPS came in at $0.00 , while revenue for the quarter reached $4.16M .
Earnings released on 15 May 2024
EPS came in at -$0.16 , while revenue for the quarter reached $3.60M .
Earnings released on 27 Mar 2024
EPS came in at -$0.44 surpassing the estimated -$0.61 by +27.87%, while revenue for the quarter reached $4.84M , missing expectations by -6.75%.
Earnings released on 14 Nov 2023
EPS came in at $0.10 surpassing the estimated -$7.50 by +101.33%, while revenue for the quarter reached $5.11M , missing expectations by -76.44%.
Earnings released on 14 Aug 2023
EPS came in at -$5.43 surpassing the estimated -$10.00 by +45.70%, while revenue for the quarter reached $2.46M , missing expectations by -85.79%.
Earnings released on 16 Jun 2023
EPS came in at -$1.85 surpassing the estimated -$15.00 by +87.67%, while revenue for the quarter reached $5.81M , missing expectations by -56.97%.
Stock split effective on 18 May 2023
Shares were split 1 : 125 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 2 Mar 2023
EPS came in at -$8.46 falling short of the estimated -$0.21 by -3.93K%, while revenue for the quarter reached $181.00K , missing expectations by -98.60%.
Earnings released on 6 Jan 2023
EPS came in at -$5.00 falling short of the estimated -$0.25 by -1.90K%, while revenue for the quarter reached $6.37M , missing expectations by -31.50%.
Earnings released on 12 Aug 2022
EPS came in at -$571.25 falling short of the estimated -$126.25 by -352.48%, while revenue for the quarter reached $6.03M , missing expectations by -0.75%.
Earnings released on 10 May 2022
EPS came in at -$360.00 surpassing the estimated -$373.75 by +3.68%, while revenue for the quarter reached $4.25M , meeting expectations.
Stock split effective on 6 May 2022
Shares were split 1 : 15 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 3 Mar 2022
EPS came in at -$618.44 falling short of the estimated -$431.03 by -43.48%, while revenue for the quarter reached $3.57M , missing expectations by -13.98%.
Earnings released on 15 Nov 2021
EPS came in at -$543.48 surpassing the estimated -$562.22 by +3.33%, while revenue for the quarter reached $1.71M , beating expectations by +17.17%.
Earnings released on 11 Aug 2021
EPS came in at -$506.00 surpassing the estimated -$655.92 by +22.86%, while revenue for the quarter reached $1.86M , missing expectations by -30.71%.
Earnings released on 6 May 2021
EPS came in at -$1.05K falling short of the estimated -$918.29 by -14.29%, while revenue for the quarter reached $1.11M , missing expectations by -32.21%.
Earnings released on 4 Mar 2021
EPS came in at -$937.03 falling short of the estimated -$674.66 by -38.89%, while revenue for the quarter reached $168.00K , missing expectations by -90.06%.
Earnings released on 9 Nov 2020
EPS came in at -$618.44 surpassing the estimated -$824.59 by +25.00%, while revenue for the quarter reached $278.00K , missing expectations by -13.73%.
EVFM Stock Performance
Access detailed EVFM performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.